Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BioAmber Inc. (BIOA)
|
Add to portfolio |
|
|
|
| Price: |
$0.01
| | Metrics |
| OS: |
129.5
|
M
| |
-449
|
% ROE
|
| Market cap: |
$1.66
|
M
| |
-60
|
% ROIC
|
|
Net debt:
|
$32.5
|
M
| |
|
|
|
EV:
|
$34.2
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($27.3)
|
M
| |
|
|
|
EBIT
|
($32.4)
|
M
| |
|
|
| EPS |
($2.35)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 14.6 | 4.2 | 2.2 | 1.5 | 2.7 | 2.3 | 0.6 |
| Revenue growth | 245.1% | 94.6% | 40.8% | -42.1% | 16.3% | 309.0% | |
| Cost of goods sold | 22.3 | 13.7 | 2.6 | 6.0 | 2.7 | 1.7 | 0.8 |
| Gross profit | -7.7 | -9.4 | -0.4 | -4.5 | 0.0 | 0.5 | -0.3 |
| Gross margin | -53.1% | -223.4% | -20.3% | -291.7% | -0.9% | 23.8% | -49.4% |
| Sales and marketing | 1.9 | 2.9 | 4.0 | 4.5 | 4.7 | 4.2 | 2.5 |
| Research and development | 5.5 | 7.2 | 20.3 | 15.2 | 16.6 | 20.4 | 16.7 |
| General and administrative | 12.4 | 9.5 | 10.6 | 10.7 | 9.8 | 11.7 | 6.8 |
| EBITA | -32.2 | -29.4 | -37.3 | -35.2 | -31.5 | -35.6 | 26.9 |
| EBITA margin | -221.0% | -696.1% | -1718.2% | -2278.2% | -1183.5% | -1553.1% | 4794.6% |
| Amortization of intangibles | 0.2 | 0.2 | 0.1 | 0.1 | 1.0 | 2.0 | |
| EBIT | -32.4 | -29.6 | -37.4 | -35.2 | -32.5 | -37.6 | 26.9 |
| EBIT margin | -222.4% | -701.1% | -1721.4% | -2281.5% | -1221.1% | -1641.9% | 4794.6% |
| Pre-tax income | -102.1 | -28.3 | -41.2 | -47.3 | 27.8 | 39.5 | 30.7 |
| Income taxes | 0.1 | 0.0 | 0.0 | 0.1 | -0.1 | -0.1 | -0.1 |
| Tax rate | | | 0.0% | | | | |
| Net income | -98.2 | -22.5 | -37.2 | -46.5 | 27.4 | 39.4 | 30.9 |
| Net margin | -673.0% | -531.9% | -1713.9% | -3011.8% | 1026.3% | 1717.4% | 5506.9% |
| |
| Diluted EPS | ($2.34) | ($0.78) | ($1.52) | ($2.32) | $1.75 | $3.82 | $3.92 |
| Shares outstanding (diluted) | 41.9 | 28.7 | 24.5 | 20.0 | 15.6 | 10.3 | 7.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|